X-37 is a pharmaceutical discovery and development company, which uses advanced artificial intelligence technology from Atomwise, Inc., to screen vast libraries of chemical compounds against high value pharmaceutical targets. X-37 develops these novel drug candidates under an innovative LLC structure which allows the sale or partnership of individual development programs in a simple and efficient manner. The team at X-37 possesses deep expertise in pharmaceutical development and the selection of pharmaceutical targets of high importance.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/15/19 | $14,500,000 | Series A |
Alpha Intelligence Capital DCVC  Hemi Ventures | undisclosed |
